Status:
COMPLETED
Intervention Study of Vitamin D Supplementation to Prevent Cardiovascular Disease
Lead Sponsor:
Chinese PLA General Hospital
Conditions:
Vitamin D Deficiency
Eligibility:
All Genders
20-90 years
Phase:
NA
Brief Summary
This is a 9 months, randomized, single center, open-label, parallel-group study to compare the efficacy and safety parameters of vitamin D supplementation in vitamin D deficiency subjects in China.
Detailed Description
This is a 9 months, randomized, single center, open-label, parallel-group study to compare the efficacy and safety parameters of vitamin D supplementation in vitamin D deficiency subjects in China. E...
Eligibility Criteria
Inclusion
- Informed consent obtained before any trial-related activities. (Trial- related activities are any procedure that would not have been performed during normal management of the subject.)
- 25OHD\<30ng/ml
Exclusion
- Severe systemic disease (including severe heart, liver, kidney and lung diseases, severe infection, mental disorder and connective tissue disease)
- Primary hyperparathyroidism, other bone disease, malabsorption and other chronic gastrointestinal disease.
- Pregnant, breast-feeding or the intention of becoming pregnant or not using adequate contraceptive measures.
- Use of systemic or inhaled glucocorticoids or other medication known to interfere with bone metabolism.
- Use of vitamin D related agents in recent 3 months.
Key Trial Info
Start Date :
June 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2015
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03339427
Start Date
June 1 2014
End Date
June 1 2015
Last Update
November 13 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PLA General Hospital
Beijing, Beijing Municipality, China, 100853